MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-01-31.

Income Overview

Net Income
-$2,565K
EPS
-$0.08
Unit: Thousand (K) dollars

Income Statement
2026-01-31
2025-10-31
2025-07-31
2025-04-30
Revenue
--0 -
Research and development expenses (including non-cash stock-based compensation expenses of 338 and 397, respectively)
1,102 1,506* 1,055 1,322
General and administrative expenses (including non-cash stock-based compensation expenses of 458 and 658, respectively)
1,614 2,037* 1,381 1,681
Total operating costs and expenses
2,716 3,542 2,436 3,003
Loss from operations
-2,716 -3,542* -2,436 -3,003
Interest income
131 154* 156 190
Net loss
-2,585 -3,388* -2,280 -2,813
Less net loss attributable to noncontrolling interest
-20 -33* -22 -23
Net loss attributable to common shareholders
-2,565 -3,355 -2,258 -2,790
Basic EPS
-0.08 0.052 -0.07 -0.09
Diluted EPS
-0.08 0.052 -0.07 -0.09
Basic Average Shares
33,240,000 -64,580,638 32,476,000 32,202,000
Diluted Average Shares
33,240,000 -64,580,638 32,476,000 32,202,000
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$2,565K Less net lossattributable to...-$20K Net loss-$2,585K Interest income$131K Loss from operations-$2,716K Total operating costsand expenses$2,716K General andadministrative expenses...$1,614K Research and developmentexpenses (including...$1,102K

Anixa Biosciences Inc (ANIX)

Anixa Biosciences Inc (ANIX)